Benefit and costs of anti-hypertensive treatment

Area of Science:

• Cardiology
• Nephrology
• Public Health

Background:

• Hypertension is a leading global risk factor for cardiovascular mortality, morbidity, and overall mortality.
• Inadequately treated hypertension leads to chronic, disabling diseases like stroke, coronary heart disease, heart failure, and kidney insufficiency.
• These conditions necessitate frequent hospitalizations and expensive medical management.

Purpose of the Study:

• To highlight the significant cardiovascular risks associated with hypertension.
• To emphasize the benefits of anti-hypertensive treatment in reducing cardiovascular complications and mortality.
• To explore strategies for improving the cost-benefit ratio of hypertension management through 24-hour blood pressure control.

Main Methods:

• Review of existing clinical trial data and medical literature on hypertension management.
• Analysis of the correlation between 24-hour average blood pressure and blood pressure variability with hypertension-related end-organ damage.
• Consideration of treatment strategies focusing on 24-hour blood pressure profiles.

Main Results:

• Anti-hypertensive treatment demonstrably reduces hypertension-related cardiovascular risk and mortality.
• 24-hour average blood pressure and blood pressure variability are more closely linked to end-organ damage than clinic-based measurements.
• Current clinical benefits of treatment may be underestimated.

Conclusions:

• Optimizing hypertension management through 24-hour blood pressure monitoring and control is essential.
• New anti-hypertensive agents that provide smooth 24-hour blood pressure reduction hold promise for further decreasing end-organ damage.
• Improved cost-benefit ratios in hypertension care can be achieved through targeted treatment strategies.